Screener
10x Genomics, Inc. TXG Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Contingent consideration, current | 7,069 | 23,363 |
| Total current liabilities | 118,509 | 153,454 |
| Contingent consideration, noncurrent | 2,991 | 1,237 |
| Operating lease liabilities, noncurrent | 66,781 | 73,376 |
| Deferred revenue, noncurrent | 9,683 | 10,501 |
| Other noncurrent liabilities | 6,556 | 6,471 |
| Total liabilities | 204,520 | 245,039 |
| Commitments and contingencies (Note 5) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is 10x Genomics, Inc.'s operating lease liabilities?
- 10x Genomics, Inc. (TXG) reported operating lease liabilities of $66.78M in Q2 2026.
- How has 10x Genomics, Inc.'s operating lease liabilities changed year-over-year?
- 10x Genomics, Inc.'s operating lease liabilities decreased by 13.4% year-over-year, from $77.08M to $66.78M.
- What is the long-term trend for 10x Genomics, Inc.'s operating lease liabilities?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s operating lease liabilities has grown at a 5.2% compound annual growth rate (CAGR), from $57.04M to $73.38M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about 10x Genomics, Inc.'s operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude